Catalyst Pharmaceuticals, Inc. (CPRX) is a pharmaceutical company that develops and commercializes treatments for rare diseases. Its primary product is FIRDAPSE, which is subject to ongoing patent litigation with Paragraph IV challengers. The company's common stock trades on the Nasdaq Capital Market under the symbol 'CPRX' and it has an active share repurchase program authorizing up to $200 million in buybacks.
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001193125-26-071525 | EDGAR | 94K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027714 | EDGAR | 86K words |
| 2024-02-28 | 2023-12-31 | 0001193125-24-050908 | EDGAR | 89K words |
| 2023-03-15 | 2022-12-31 | 0001193125-23-071299 | EDGAR | — |
| 2022-03-16 | 2021-12-31 | 0001193125-22-077228 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001193125-21-081545 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001193125-20-075048 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001193125-19-078253 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001193125-18-082292 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001193125-17-083667 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001193125-25-266854 | EDGAR | 38K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104000 | EDGAR | 37K words |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065652 | EDGAR | 33K words |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122282 | EDGAR | 36K words |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092745 | EDGAR | 36K words |
| 2024-05-08 | 2024-03-31 | 0001193125-24-134195 | EDGAR | 34K words |
| 2023-11-08 | 2023-09-30 | 0001193125-23-273506 | EDGAR | 37K words |
| 2023-08-09 | 2023-06-30 | 0001193125-23-207344 | EDGAR | 35K words |
| 2023-05-10 | 2023-03-31 | 0001193125-23-140701 | EDGAR | 30K words |
| 2022-11-09 | 2022-09-30 | 0001193125-22-281202 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001193125-22-216148 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001193125-22-146274 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-16 | 0001193125-26-304984 | EDGAR | 10K words |
| 2026-03-18 | 0001193125-26-114306 | EDGAR | 0K words |
| 2026-02-25 | 0001193125-26-071702 | EDGAR | 5K words |
| 2026-01-12 | 0001193125-26-009822 | EDGAR | 2K words |
| 2025-11-05 | 0001193125-25-267038 | EDGAR | 4K words |
| 2025-10-01 | 0001193125-25-226837 | EDGAR | 1K words |
| 2025-08-25 | 0001193125-25-187733 | EDGAR | 1K words |
| 2025-08-07 | 0001193125-25-175477 | EDGAR | 1K words |
| 2025-08-06 | 0001193125-25-174540 | EDGAR | 4K words |
| 2025-08-04 | 0001193125-25-172653 | EDGAR | 1K words |
330 total filings indexed. 298 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001369568 |
| Ticker | CPRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.catalystpharma.com |
| Listed | 2006-11-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CPRX (~200 tokens, structured JSON with cryptographic provenance)